This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Hospitalier Régional Universitaire De Tours, National Institute of Health and Medical Research, Universite De Tours. Active years: 2014-2020.
Company Filing History:
1 out of 5 
1 out of 1,853 
1 out of 19 Years Active: 2014-2020
Title: Innovations of Philippe Roingeard in Vaccine Development
Introduction
Philippe Roingeard, an inventor based in Savonnieres, France, has made significant contributions to the field of biotechnology, particularly in vaccine development. With two patents to his name, his work revolves around the creation of fusion proteins that play a crucial role in combating viral infections such as hepatitis B and C, as well as Zika virus.
Latest Patents
Roingeard's latest patents include groundbreaking innovations in the realm of immunogenic fusion proteins. The first patent focuses on a fusion protein that comprises peptides derived from the proteins of both human hepatitis B virus (HBV) and Zika virus. This unique combination aims to enhance the effectiveness of vaccines by incorporating essential amino acid sequences that improve immunogenicity.
The second patent further elaborates on his work with hepatitis C, describing a fusion protein that combines elements of HBV with the envelope proteins of HCV. This invention includes a hybrid nucleic acid molecule that encodes the fusion protein and emphasizes the potential for developing immunogenic compositions and subviral particles necessary for vaccine production.
Career Highlights
Philippe Roingeard has worked with renowned institutions such as Université François Rabelais de Tours and Université de Tours, where he has engaged in extensive research and development. His innovative work has paved the way for new therapeutic approaches and potential vaccine candidates against viral diseases.
Collaborations
Throughout his career, Roingeard has collaborated with notable researchers, including Christophe Hourioux and Romuald Patient. These partnerships have been instrumental in advancing his research and bringing his inventions to fruition.
Conclusion
With a focus on creating effective vaccine strategies through the development of fusion proteins, Philippe Roingeard stands as a prominent figure in the field of immunology. His inventions not only highlight the importance of innovative research but also underscore the potential for further advancements in vaccine technology to combat infectious diseases.